Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,044 | -66,318 | -35,996 | -95,496 | -29,782 |
| Depreciation Amortization | 2,792 | 1,858 | 894 | 2,029 | 1,270 |
| Accounts receivable | -2,821 | -5,793 | -4,178 | -13,876 | -8,695 |
| Accounts payable and accrued liabilities | 2,516 | 1,828 | -722 | 686 | 441 |
| Other Working Capital | -27,224 | -34,771 | -32,506 | 26,480 | -255 |
| Other Operating Activity | 21,173 | 19,393 | 13,511 | 2,064 | -11,084 |
| Operating Cash Flow | $-89,608 | $-83,803 | $-58,997 | $-78,113 | $-48,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,957 | -2,503 | -28,796 | -264,725 | 3,496 |
| PPE Investments | -288 | -288 | -317 | -2,169 | -750 |
| Purchase Sale Intangibles | -3,500 | -3,500 | -3,500 | -17,100 | -17,100 |
| Other Investing Activity | -3,500 | -3,500 | -3,500 | 35,900 | 35,900 |
| Investing Cash Flow | $7,169 | $-6,291 | $-32,613 | $-230,994 | $38,646 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 748 | 748 | 0 | 201,385 | 201,440 |
| Other Financing Activity | 0 | 0 | 0 | 1,906 | 0 |
| Financing Cash Flow | $748 | $748 | $0 | $203,291 | $201,440 |
| Beginning Cash Position | 124,968 | 124,968 | 124,968 | 230,784 | 230,784 |
| End Cash Position | 43,277 | 35,622 | 33,358 | 124,968 | 422,765 |
| Net Cash Flow | $-81,691 | $-89,346 | $-91,610 | $-105,816 | $191,981 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,608 | -83,803 | -58,997 | -78,113 | -48,105 |
| Capital Expenditure | -320 | -320 | -317 | -2,169 | -750 |
| Free Cash Flow | -89,928 | -84,123 | -59,314 | -80,282 | -48,855 |